Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends

Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends


Report Summary

Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Trends Report is a comprehensive and easily accessible overview of Becton, Dickinson and Company's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Becton, Dickinson and Company including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Becton, Dickinson and Company's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Becton, Dickinson and Company's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Becton, Dickinson and Company's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Becton, Dickinson and Company's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Becton, Dickinson and Company enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications. BD’s operations consist of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. The company was incorporated under the laws of the State of New Jersey in November 1906 with headquartered in United States.

Becton, Dickinson and Company in the News:-

- 10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials

- 10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023

- 03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024

- 26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases

- 20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts

Scope
  • Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
  • Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
  • Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
  • Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
  • Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
  • Comprehensive Understanding of the Becton, Dickinson and Company's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
  • Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
  • Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
  • Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
  • Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
  • Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Becton, Dickinson and Company:
  • Becton, Dickinson and Company Value Chain Analysis
  • Becton, Dickinson and Company Porter's Five Forces Analysis
  • Becton, Dickinson and Company VRIO Analysis
  • Becton, Dickinson and Company BCG Analysis
  • Becton, Dickinson and Company Segmentation, Targeting and Positioning (STP) Analysis
  • Becton, Dickinson and Company Ansoff Matrix Analysis


COMPANY EXECUTIVE SUMMARY
Table of Contents
Tables
Charts
Becton, Dickinson and Company - Key Company Facts
Becton, Dickinson and Company - Company Description
Becton, Dickinson and Company - Top Executives
Becton, Dickinson and Company- Top Executives Biographies
Becton, Dickinson and Company- Head Office & Locations
Head Office - Country
Key Subsidiaries
Becton, Dickinson and Company - Products and Services
Products
Becton, Dickinson and Company - Historic Events
Becton, Dickinson and Company - Company's Management Discussion
Becton, Dickinson and Company - Corporate Strategy
Becton, Dickinson and Company - Business Description
BD Medical
BD Life Sciences
BD Interventional
Becton, Dickinson and Company - ESG Spotlight
Environment
Social
Corporate Governance
Becton, Dickinson and Company - SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Becton, Dickinson and Company - PESTLE Analysis
Overview
Political Factors
Economic Factors
Social Factors
Technological Factors
Legal Factors
Environmental Factors
Becton, Dickinson and Company - Financial Deep Dive
Share Price Trend - Aug-2023 to Aug-2024 (Average Share Closing Price)
Profit and Loss Statement
Summary of Profit and Loss Statement
Balance Sheet
Summary of Balance Sheet
Cash Flow Statement
Summary of Cash Flow Statement
Key Financial Ratio Analysis
Becton, Dickinson and Company - Ratio Charts
Activity Ratio Charts
Growth Ratios Charts
Leverage Ratio Charts
Liquidity Ratio Charts
Profitability Ratio Charts
Competing Players
Snapshot of Competing Players
Baxter International Inc.
Key Company Facts
Company Description
Snapshot of Competing Players
Koninklijke Philips N.V.
Key Company Facts
Company Description
Snapshot of Competing Players
Medtronic plc
Key Company Facts
Company Description
Snapshot of Competing Players
Stryker Corporation
Key Company Facts
Company Description
Snapshot of Competing Players
Thermo Fisher Scientific Inc.
Key Company Facts
Company Description
Becton, Dickinson and Company - In the News
10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024
26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
06-May-2024 - BD, City of Hope to Offer Pharmacy Residency Program for Medication-Use Safety and Policy
30-Apr-2024 - BD Board Declares Dividend
29-Apr-2024 - BD to Present at Bank of America Securities Health Care Conference 2024
09-Apr-2024 - BD Named a Best Employer for Excellence in Employee Well-Being
27-Mar-2024 - New Survey Reveals Patients Receive Too Many Needlesticks
26-Mar-2024 - BD Named Among Fortune's Most Innovative Companies
21-Mar-2024 - BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
18-Mar-2024 - BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
13-Mar-2024 - New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
11-Mar-2024 - BD Names Rian Seger President of BD Surgery
Becton, Dickinson and Company - Key Deals
14-Mar-2024 - BD Collaborates with GOCC to Combat Sepsis in Poland
21-Feb-2024 - BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
30-Jan-2024 - BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
23-Jan-2024 - BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
20-Nov-2023 - BD, Bio Farma Collaborate to Help Eliminate Tuberculosis in Indonesia by 2030
03-Aug-2023 - Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income Countries
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Financial Deep Dive
Financial Ratios -
Activity Ratios
Growth Ratios
Leverage Ratios
Liquidity Ratios
Market Ratios
Profitability Ratios
Research Methodology
Disclaimer
Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings